Alzheimer’s disease doesn’t arrive suddenly. Instead, it emerges slowly, beginning with subtle changes that might be dismissed as normal aging before progressing through increasingly serious ...

Anavex could secure conditional approval for blarcamesine, though longer trials may be needed. Check out why AVXL stock is a ...

On March 10, around 9:20 pm, Marianthi-Anna Kioumourtzoglou, an environmental health professor at Columbia University, got ...

Scientists Identify Key Enzyme in Alzheimer's Disease That Links Brain Inflammation to Memory Loss Apr. 14, 2025 — A research team has identified a previously unknown enzyme, SIRT2, that plays a ...

Discover insights into Anavex's ATTENTION-AD OLE trial results for early Alzheimer's, presented at AD/PD 2025. Click here to ...

Now, researchers from Mass General Brigham have developed an innovative at-home smell test that could harness this knowledge to detect Alzheimer’s disease years before traditional symptoms emerge.

A recent study tests a new drug, gantenerumab on people with a genetically inherited form of Alzheimer’s disease. For people with this condition, dementia is almost inevitable. Gantenerumab ...

WEDNESDAY, April 2, 2025 (HealthDay News) -- Lower levels of “bad” LDL cholesterol could mean a lower risk of dementia and Alzheimer’s disease, a new study says. People with low-density lipoprotein ...

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease. That’s according to a new study from Washington University School of ...

2025 — While some studies have suggested that having a mother with Alzheimer's disease may put you more at risk of developing the disease, a new study finds that having a father with the disease ...